ECRI issues its annual list of the top health technology hazards

Every year, ECRI Institute’s Health Device Group issues a list identifying the top ten potential device-related sources of danger in the coming year. Along with the list, accompanying strategies for mitigating the various trouble-areas are also included.

Read more here.

Did You Know?

Your Sub-Licensed GE Software Options on your Diagnostic Imaging Equipment May NOT be Transferable?

Find out what this could mean for you here.

FDA Holds Off on UDI Label Enforcement for Devices Made Before September 2021

The FDA announced it does not intend to enforce the requirement to use its unique device identifier system for labels on medical devices manufactured and labeled before Sept. 24, 2021.  In final guidance issued Aug. 30, the agency said stakeholders had expressed concern that pharmacies and other entities in the supply chain were not prepared for the transition. The deadline for labeling most Class I and Class II devices is Sept. 24.

Read more here.

GE Healthcare Announces Terms of Software Non-Resale

On July 13, 2016, GE Healthcare sent a letter to IAMERS, which we understand was also sent to others who are brokers and resellers of GE Healthcare Medical Imaging Devices.  This letter details GE Healthcare’s policy on the Terms of Software Non-Resale.

Click here to read the letter.

Page 5 of 82« First...34567...102030...Last »